Endometrial pathologies associated with postmenopausal tamoxifen treatment

被引:201
作者
Cohen, I [1 ]
机构
[1] Tel Aviv Univ, Dept Obstet & Gynecol, Sapir Med Ctr, Sackler Fac Med, IL-44281 Kefar Sava, Israel
关键词
tamoxifen; endometrial pathologies; menopause;
D O I
10.1016/j.ygyno.2004.03.048
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To evaluate various endometrial pathologies described in association with postmenopausal tamoxifen treatment, as well as the clinical aspects of these endometrial pathologies. Methods. A search was made in PUB MED for all studies published in English, up to the end of 2003, reporting on endometrial pathologies in association with postmenopausal tamoxifen treatment. Overall 106 studies were available, and all are included in this review. The types of studies included were mostly randomized clinical trials, non-randomized cohort studies, prospective and retrospective case controlled studies. Results. Endometrial polyps represent the most common endometrial pathology associated with postmenopausal tamoxifen exposure. A high rate of malignancy was reported in these polyps. Endometrial hyperplasia, endometrial polyps, endometrial cancer and malignant mixed mesodermal tumors and sarcoma are more commonly diagnosed in postmenopausal breast cancer tamoxifen-treated patients as compared to non-treated patients. Long-term tamoxifen users are more likely to succumb to endometrial cancer and endometrial sarcomas than non-users, due to the unfavorable histology of the endometrial malignancy, and an advanced stage of diagnosis. Conclusions. The clinician should be alerted to these pathologies, which, in some cases, may potentially increase the mortality of these patients. Consequently, it is suggested that their supervision is of importance, especially if the patients experience any gynecological symptoms, including pelvic pain or pressure. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:256 / 266
页数:11
相关论文
共 111 条
[41]   Second cancers after adjuvant tamoxifen therapy for breast cancer [J].
Curtis, RE ;
Boice, JD ;
Shriner, DA ;
Hankey, BF ;
Fraumeni, JF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (12) :832-834
[42]   Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer [J].
Deligdisch, L ;
Kalir, T ;
Cohen, CJ ;
de Latour, M ;
Le Bouedec, G ;
Penault-Llorca, F .
GYNECOLOGIC ONCOLOGY, 2000, 78 (02) :181-186
[43]   ENDOMETRIAL LESIONS IN PATIENTS UNDERGOING TAMOXIFEN THERAPY [J].
DEMUYLDER, X ;
NEVEN, P ;
DESOMER, M ;
VANBELLE, Y ;
VANDERICK, G ;
DEMUYLDER, E .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1991, 36 (02) :127-130
[44]  
*EARL BREAST CANC, 1998, LANCET, V351, P15451
[45]   IS THERE AN ASSOCIATION BETWEEN LONG-TERM TAMOXIFEN TREATMENT AND THE DEVELOPMENT OF CARCINOSARCOMA (MALIGNANT MIXED MULLERIAN TUMOR) OF THE UTERUS [J].
EVANS, MJ ;
LANGLOIS, NEI ;
KITCHENER, HC ;
MILLER, ID .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (04) :310-313
[46]   MULTIPLE PRIMARY CANCERS OF THE BREAST, ENDOMETRIUM AND OVARY [J].
EWERTZ, M ;
STORM, HH .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (12) :1927-1932
[47]   Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: An ultrasound, color flow Doppler, hysteroscopic and histological study [J].
Exacoustos, C ;
Zupi, E ;
Cangi, B ;
Chiaretti, M ;
Arduini, D ;
Romanini, C .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1995, 6 (06) :435-442
[48]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388
[49]   ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14 [J].
FISHER, B ;
COSTANTINO, JP ;
REDMOND, CK ;
FISHER, ER ;
WICKERHAM, DL ;
CRONIN, WM ;
BOWMAN, D ;
COUTURE, J ;
DIMITROV, NV ;
EVANS, J ;
FARRAR, W ;
KAVANAH, M ;
LICKLEY, HL ;
MARGOLESE, R ;
PATERSON, AHG ;
ROBIDOUX, A ;
SHIBATA, H ;
TERZ, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07) :527-537
[50]  
FOMANDER T, 1989, LANCET, V1, P117